YD Bio (YDES) Current Assets (2024 - 2026)
YD Bio's (YDES) quarterly Current Assets came in at $5.6 million in Q2 2026, up 300.29% year-over-year from $1.4 million in Q2 2025, and down 42.18% quarter-over-quarter from $9.7 million in Q4 2025.
Powered by 
Analysis
YD Bio (YDES) Current Assets (2024 - 2026) Analysis & Trends
YD Bio (YDES) has reported Current Assets for 3 consecutive years, with $5.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Assets rose 300.29% year-over-year to $5.6 million in Q2 2026; TTM through Jun 2026 was $5.6 million, a 300.29% increase from a year earlier, with the FY2025 full-year figure at $9.7 million, up 178.85% from the prior year.
- Current Assets was $5.6 million for Q2 2026 at YD Bio, down from $9.7 million in the prior quarter.
- Over five years, Current Assets peaked at $9.7 million in Q4 2025 and troughed at $1.4 million in Q2 2025.
- A 3-year average of $5.0 million and a median of $4.5 million in 2024 frame the typical range for Current Assets.
- Across the five-year window, Current Assets surged 178.85% in 2025 and soared 300.29% in 2026, its largest moves.
- Over 3 years, Current Assets stood at $3.5 million in 2024, then jumped by 178.85% to $9.7 million in 2025, then plunged by 42.18% to $5.6 million in 2026.
- The last three Current Assets figures came in at $5.6 million (Q2 2026), $9.7 million (Q4 2025), and $1.4 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 34.96 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 13.95 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 12.54 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 18.45 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 5.82 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 8.07 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 7.31 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 4.74 Bn |
| 10 | YD Bio | 225.82 Mn | 223.16 Mn | - | 5.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.59 Mn |
| Dec 31, 2025 | 9.67 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Dec 31, 2024 | 3.47 Mn |
API Access
YD Bio Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=YDES&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "YDES", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=YDES&period=max&api_key=YOUR_API_KEY");
const data = await res.json();